Microsoft word - publications_paul-perco_2013-02-22.docx


{58} Evaluation of the Zucker Diabetic Fatty (ZDF) Rat as a Model for Human Disease Based on Urinary
Peptidomic Profiles.
Siwy J, Zoja C, Klein J, Benigni A, Mullen W, Mayer B, Mischak H, Jankowski J, Stevens R, Vlahou A,
Kossida S, Perco P, Bahlmann FH.
PLoS One 2012 7(12):e51334
{57} Increased renal versican expression is associated with progression of chronic kidney disease. Rudnicki M, Perco P, Neuwirt H, Noppert SJ, Leierer J, Sunzenauer J, Eder S, Zoja C, Eller K,
Rosenkranz A, Müller GA, Mayer B, Mayer G
{56} Data graphs for linking clinical phenotype and molecular feature space. Heinzel A, Fechete R, Söllner J, Perco P, Heinze G, Oberbauer R, Mayer G, Lukas A, Mayer B
{55} Molecular pathways and crosstalk characterizing the cardiorenal syndrome. Mühlberger I, Mönks K, Fechete R, Mayer G, Oberbauer R, Mayer B, Perco P
{54} In-silico human genomics with GeneCards. Stelzer G, Dalah I, Stein TI, Satanower Y, Rosen N, Nativ N, Oz-Levi D, Olender T, Belinky F, Bahir I,
Krug H, Perco P, Mayer B, Kolker E, Safran M, Lancet D
{53} Linking molecular feature space and disease terms for the immunosuppressive drug rapamycin. Bernthaler A, Mönks K, Mühlberger I, Mayer B, Perco P, Oberbauer R
{52} Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy. Fechete R, Heinzel A, Perco P, Mönks K, Söllner J, Stelzer G, Eder S, Lancet D, Oberbauer R, Mayer G,
Mayer B
Proteomics Clinical Applications 2011 5(5-6):354-66 {51} Mycophenolate mofetil associated molecular profiles and diseases Mönks K, Bernthaler A, Mühlberger I, Mayer B, Oberbauer R, Perco P
{50} Computational analysis workflows for Omics data interpretation Mühlberger I, Wilflingseder J, Bernthaler A, Fechete R, Lukas A, Perco P
{49} Data and knowledge management in cross-Omics research projects Wiesinger M, Haiduk M, Behr M, de Abreu Madeira HL, Glöckler G, Perco P, Lukas A
{48} Recurrence free survival in prostate cancer is related to increased stromal TRAIL expression Anees M, Horak P, El-Gazzar A, Susani M, Heinze G, Perco P, Pangerl T, Loda M, Lis r, Krainer M, Oh
{47} Synthetic lethal hubs associated with vincristine resistant neuroblastoma. Fechete R, Barth S, Olender T, Munteanu A, Bernthaler A, Inger A, Perco P, Lukas A, Lancet D, Cinatl Jr
J, Michaelis M, Mayer B
{46} Integrative bioinformatics analysis of proteins associated with the cardiorenal syndrome. Mühlberger I, Mönks K, Bernthaler A, Mayer B, Mayer G, Oberbauer R, Perco P
Int J Nephrol 2011 2011, Article ID809378, 10 pages {45} Adaptive trimmed t-statistics for identifying predominantly high expression in a microarray experiment. Gleiss A, Sanchez-Cabo F, Perco P, Tong D, Heinze G
{44} Molecular biomarker candidates of acute kidney injury in zero-hour renal transplant needle biopsies. Korbely R, Wilflingseder J, Perco P, Kainz A, Langer RM, Mayer B, Oberbauer R
{43} Integrative analysis of –omics data and histological scoring in renal disease and transplantation: renal Perco P, Oberbauer R
{42} Steroid pretreatment of organ donors to prevent postischemic renal allograft failure: a randomized, Kainz A, Wilflingseder J, Mitterbauer C, Haller M, Burghuber C, Perco P, Langer RM, Heinze G,
Oberbauer R.
{41} Linking transcriptomic and proteomic data on the level of protein interaction networks. Perco P, Mühlberger I, Mayer G, Oberbauer R, Lukas A, Mayer B.
{40} Natural immunity enhances the activity of a DR5 agonistic antibody and carboplatin in the treatment of El-Gazzar A, Perco P, Eckelhart E, Anees M, Sexl V, Mayer B, Liu Y, Mikulits W, Horvat R, Pangerl T,
Zheng D, Krainer M
{39} The role of c-FLIP(L) in ovarian cancer: Chaperoning tumor cells from immunosurveillance and increasing El-Gazzar A, Wittinger M, Perco P, Anees M, Horvat R, Mikulits W, Grunt TW, Mayer B, Krainer M
{38} Systems biology: opening new avenues in clinical research. Molina F, Dehmer M, Perco P, Graber A, Girolami F, Spasovski G, Schanstra JP, Vlahou A
Nephrol Dial Transplant 2010 25(4):1015-8
{37} Impaired metabolism in donor kidney graft after steroid pretreatment. Wilflingseder J, Kainz A, Mühlberger I, Perco P, Langer R, Kristo I, Mayer B, Oberbauer R
{36} Computational reconstruction of protein interaction networks. Mönks K, Mühlberger I, Bernthaler A, Fechete R, Perco P, Freund R, Lukas A, Mayer B
in Applied Statistics for Network Biology: Methods in Systems Biology 2011 Wiley-VCH
{35} Biocompatibility of peritoneal dialysis solutions determined by genomics of human leucocytes: a cross- over study.
Wilflingseder J, Perco P, Kainz A, Schwarz C, Korbely R, Mayer B, Oberbauer R
NDT Plus 2009 2:510-12
{34} Biomarkers in renal transplantation ischemia reperfusion injury. Mühlberger I, Perco P, Fechete R, Mayer B, Oberbauer R.
{33} Neuropilin-1 and neuropilin-2 are differentially expressed in human proteinuric nephropathies and cytokine-stimulated proximal tubular cells. Schramek H, Sarközi R, Lauterberg C, Kronbichler A, Pirklbauer M, Albrecht R, Noppert SJ, Perco P,
Rudnicki M, Strutz FM, Mayer G
{32} A dependency graph approach for the analysis of differential gene expression profiles. Bernthaler A, Mühlberger I, Fechete R, Perco P, Lukas A, Mayer B.
{31} Microarray and Bioinformatics Analysis of Gene Expression in Experimental Membranous Nephropathy. Hauser PV*, Perco P*, Mühlberger I, Pippin J, Blonski M, Mayer B, Alpers CE, Oberbauer R, Shankland
Nephron Exp Nephrol. 2009 112(2):e43-e58.
{30} Inter-laboratory comparison of human renal proximal tubule (HK-2) transcriptome alterations due to cyclosporine A exposure and medium exhaustion. Jennings P, Aydin S, Bennett J, McBride R, Weiland C, Tuite N, Gruber L, Perco P, O’Gaora P, Ellinger-
Ziegelbauer H, Ahr HJ, Van Kooten C, Daha M Ryan MP, Pfaller W, McMorrow T.
{29} Histogenomics: Association of gene expression patterns with histological parameters in kidney biopsies. Perco P, Kainz A, Wilflingseder J, Soleiman A, Mayer B, Oberbauer R.
{28} Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and Rudnicki M*, Perco P*, Enrich J, Eder S, Heininger D, Bernthaler A, Wiesinger M, Sarközi R, Noppert SJ,
Schramek H, Mayer B, Oberbauer R, Mayer G.
{27} Molecular predictors for anemia after kidney transplantation. Wilflingseder J, Kainz A, Perco P, Korbely R, Mayer B, Oberbauer R.
Nephrol Dial Transplant. 2009 24(3):1015-23. {26} Biocompatibility of haemodialysis membranes determined by gene expression of human leucocytes: a Wilflingseder J, Perco P, Kainz A, Korbely R, Mayer B, Oberbauer R.
{25} Bortezomib-Induced Survival Signals and Genes in Human Proximal Tubular Cells. Sarkozi R, Perco P, Hochegger K, Enrich J, Wiesinger M, Pirklbauer M, Eder S, Rudnicki M, Rosenkranz
AR, Mayer B, Mayer G, Schramek H.
J Pharmacol Exp Ther. 2008 327(3):645-56. {24} The surface properties of nanocrystalline diamond and nanoparticulate diamond powder and their suitability as cell growth support surfaces. Lechleitner T, Klauser F, Seppi T, Lechner J, Jennings P, Perco P, Mayer B, Steinmüller-Nethl D, Preiner
J, Hinterdorfer P, Hermann M, Bertel E, Pfaller K, Pfaller W.
{23} Present status at the Vienna Transplantation Center after four thousand renal transplantations. Bodingbauer M, Kramar R, Wekerle T, Böhmig GA, Berlakovich G, Säemann MD, Steininger R, Perco P,
Oberbauer R, Hörl W, Mühlbacher F.
{22} Kidney injury molecule-1 as a biomarker of acute kidney injury in renal transplant recipients. Perco P, Oberbauer R.
{21} Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation. Koppelstaetter C, Schratzberger G, Perco P, Hofer J, Mark W, Ollinger R, Oberbauer R, Schwarz C,
Mitterbauer C, Kainz A, Karkoszka H, Wiecek A, Mayer B, Mayer G.
{20} Biomarker candidates for cardiovascular disease and bone metabolism disorders in chronic kidney Perco P, Wilflingseder J, Bernthaler A, Wiesinger M, Rudnicki M, Wimmer B, Mayer B, Oberbauer R.
{19} Analysis and prediction of protective continuous B-cell epitopes on pathogen proteins. Sollner J, Grohmann R, Rapberger R, Perco P, Lukas A, Mayer B.
Immunome Res 2008 4(1):1.
{18} Linking the ovarian cancer transcriptome and immunome. Rapberger R, Perco P, Sax C, Pangerl T, Siehs C, Pils D, Bernthaler A, Lukas A, Mayer B, Krainer M.
BMC Syst Biol 2008 2(1):2.
{17} The influence of microvascular endothelial cells on transcriptional regulation of proximal tubular epithelial cells.
Aydin S, Signorelli S, Lechleitner T, Joannidis M, Perco P, Pleban C, Pfaller W, Jennings P.
Am J Physiol Cell Physiol 2008 294(2):C543-54.
{16} In vitro - transcriptional response of polymorphonuclear leukocytes following contact with different antigens.
Hochegger K*, Perco P*, Enrich J, Mayer B, Mayer G, Rosenkranz AR, Rudnicki M.
Eur J Clin Invest 2007 37(11):860-9.
{15} Characterization of protein interaction networks in tumors. Platzer A, Perco P, Lukas A, Mayer B
BMC Bioinformatics 2007 8(1):224.
{14} Gene-expression profiles and age of donor kidney biopsies obtained before transplantation distinguish medium term graft function.
Kainz A, Perco P, Mayer B, Soleiman A, Steininger R, Mayer G, Mitterbauer C, Schwarz C, Meyer TW,
Oberbauer R
Transplantation 2007 83(8):1048-54.
{13} Gene expression profiles of human proximal tubular epithelial cells in proteinuric nephropathies. Rudnicki M, Eder S, Perco P, Enrich J, Scheiber K, Koppelstätter C, Schratzberger G, Mayer B,
Oberbauer R, Meyer TW, Mayer G
Kidney Int 2007 71(4):325-35.
{12} Gene expression and biomarkers in renal transplant ischemia reperfusion injury. Perco P, Pleban C, Kainz A, Lukas A, Mayer B, Oberbauer R
Transpl Int 2007 20(1):2-11.
{11} Protein biomarkers associated with acute renal failure and chronic kidney disease. Perco P, Pleban C, Kainz A, Lukas A, Mayer G, Mayer B, Oberbauer R
Eur J Clin Invest 2006 36(11):753-63.
{10} Transforming omics data into context: Bioinformatics on genomics and proteomics raw data. Perco P, Rapberger R, Siehs C, Lukas A, Oberbauer R, Mayer G, Mayer B
Electrophoresis 2006 27(13):2659-75.
{09} Molecular signature of mice T-lymphocytes following tolerance induction by BMT and CD40-CD40L costimulation blockade.
Perco P, Blaha P, Kainz A, Mayer B, Hauser P, Wekerle T, Oberbauer R
Transpl Int 2006 19(2):146-57.
{08} Identification of statistically over-represented combinations of transcription factor binding sites in sets of co-expressed genes.
Huang SS, Fulton DL, Arenillas DJ, Perco P, Ho Sui SJ, Mortimer JR, Wasserman WW
Advances in Bioinformatics and Computational Biology 2006 3:247-56.
{07} Transcriptional response in the unaffected kidney after contralateral hydronephrosis or nephrectomy. Hauser P, Kainz A, Perco P, Bergmeister H, Mitterbauer C, Schwarz C, Regele HM, Mayer B, Meyer TW,
Oberbauer R
Kidney Int 2005 68(6):2497-07.
{06} Effect of tissue fixation on telomere length determination by quantitative PCR. Mechanisms of Ageing and Development.
Koppelstätter C, Jennings P, Hochegger K, Perco P, Ischia R, Karkoszka H, Mayer G
Mech Ageing Dev 2005 126(12):1331-3.
{05} Detection of coregulation in differential gene expression profiles. Perco P, Kainz A, Mayer G, Lukas A, Oberbauer R, Mayer B
Biosystems 2005 82(3):235-47.
{04} Alterations in gene expression in cadaveric vs. live donor kidneys suggest impaired tubular counterbalance of oxidative stress at implantation.
Kainz A, Mitterbauer C, Hauser P, Schwarz C, Regele HM, Berlakovich G, Mayer G, Perco P, Mayer B,
Meyer TW, Oberbauer R
Am J Transplant 2004 Oct;4(10):1595-604.
{03} Genome wide gene expression patterns of donor kidney biopsies distinguish primary allograft function. Hauser P, Schwarz C, Mitterbauer C, Regele HM, Mühlbacher F, Mayer G, Perco P, Mayer B, Meyer TW,
Oberbauer R
Lab Invest 2004 Mar;84(3):353-61.
{02} Testing for the D zygosity with three different methods revealed altered Rhesus boxes and a new weak D type.
Perco P, Shao CP, Mayr WR, Panzer S, Legler TJ
Transfusion 2003 Mar;43(3):335-9.
{01} RHD sequencing: a new tool for decision making on transfusion therapy and provision of Rh prophylaxis. Legler TJ, Maas JH, Kohler M, Wagner T, Daniels GL, Perco P, Panzer S
Transfus Med 2001 Oct;11(5):383-8.


American Academy of Periodontology Standardized Format for Drug References Following is a list of drugs (generic and trade name) that you may be using in your test items. The AAP test construction committee has reviewed each of the following and developed a standardized format so that all items on the exam refer to each drug in the same fashion. Please use the format listed bel

nicht durch Gabe von Schleifendiuretika!). – In Kombination mit Gemcitabin wird Cis-führt werden!Bei ordnungsgemäßer Prä- und Posthydra-Eine Durchstechflasche mit 20 ml Infusions-tation und normaler Nierenfunktion kann beiEine Durchstechflasche mit 50 ml Infusions-Gabe von Mannitol zur Induktion einer Diure-– In Kombination mit Vinorelbin wird Cispla-se durch sorgfältige Flüssigk

Copyright © 2010-2014 Medical Pdf Finder